Welcome to our dedicated page for Adapthealth news (Ticker: AHCO), a resource for investors and traders seeking the latest updates and insights on Adapthealth stock.
AdaptHealth Corp (AHCO) delivers essential home medical equipment and healthcare-at-home services, empowering patients through respiratory care, mobility solutions, and chronic condition management. This page provides centralized access to all official company announcements and market-relevant developments.
Investors and healthcare professionals will find timely updates on earnings reports, regulatory milestones, product launches, and strategic partnerships. Our curated collection includes press releases on sleep therapy innovations, respiratory equipment advancements, and operational expansions across AHCO's nationwide network.
Key areas covered include quarterly financial results, clinical service enhancements, Medicare/Medicaid compliance updates, and technology integrations in home healthcare. All content is sourced directly from AdaptHealth's communications to ensure accuracy and relevance for stakeholders.
Bookmark this page for streamlined access to AHCO's latest business developments. Check regularly for updates impacting the home healthcare sector and AdaptHealth's position within this critical industry.
AdaptHealth Corp. (NASDAQ: AHCO) will announce its Q2 2022 financial results before market open on
AdaptHealth Corp. (NASDAQ: AHCO) has announced that
AdaptHealth is a leader in providing patient-centered healthcare-at-home solutions, serving approximately 3.9 million patients annually across the United States.
AdaptHealth Corp. (NASDAQ: AHCO) will participate in a fireside chat at the UBS Global Healthcare Conference on May 25, 2022, at 10:00 am ET. President Josh Parnes and CFO Jason Clemens will represent the Company, a leader in patient-centered healthcare-at-home solutions. Interested parties can access a live webcast on AdaptHealth's website. The Company serves around 3.9 million patients annually through over 750 locations nationwide, offering medical equipment and services designed for chronic condition management.
AdaptHealth Corp. (NASDAQ: AHCO) announced participation in a fireside chat at the RBC Capital Markets 2022 Global Healthcare Conference on May 17, 2022, at 10:30 am ET. President Josh Parnes and CFO Jason Clemens will represent the company. A live webcast will be available on AdaptHealth’s website, which should be accessed 5-10 minutes before the session. AdaptHealth is a leader in patient-centered healthcare-at-home solutions, serving approximately 3.9 million patients annually across the U.S.
AdaptHealth Corp. (NASDAQ: AHCO) announced strong financial results for Q1 2022, with net revenue of $706.2 million, a 46.5% increase from the previous year. Adjusted EBITDA rose 32.1% to $137.6 million. The company reported a net income of $41.8 million compared to a net loss of $4.0 million in Q1 2021. A share repurchase program for up to $200 million was authorized, reflecting confidence in the company's outlook. AdaptHealth has continued to address challenges from CPAP equipment shortages and has completed six acquisitions this year, with updated revenue guidance for 2022 between $2.840 billion and $3.040 billion.
AdaptHealth Corp. (NASDAQ: AHCO) announced participation in a fireside chat at the BofA Securities 2022 Healthcare Conference on May 11 at 12:40 pm PT. CEO Steve Griggs and CFO Jason Clemens will lead the discussion, which can be accessed via a live webcast on AdaptHealth's website. The company is a leader in providing patient-centered healthcare-at-home solutions, serving approximately 3.8 million patients annually across the U.S. through over 750 locations. This includes services for chronic conditions like sleep apnea and diabetes.
AdaptHealth Corp. (NASDAQ: AHCO) will release its Q1 2022 financial results on May 10, 2022, before market opening. A teleconference will follow at 8:30 a.m. ET for discussions regarding the results and business activities. This company is a leader in patient-centered healthcare-at-home solutions, offering products like sleep therapy equipment, diabetes supplies, and oxygen services through a network covering approximately 3.8 million patients in 47 states.
AdaptHealth Corp. (NASDAQ: AHCO) reported exceptional results for 2021, with revenues soaring to $2.45 billion, more than double the $1.06 billion from 2020. The company serves around 3.8 million patients annually, despite facing challenges from CPAP shortages. The fourth quarter revenue reached a record $702.1 million, marking a 102% increase year-over-year. Net income for the quarter was $22.9 million, a significant recovery from a net loss of $80.5 million in Q4 2020. AdaptHealth updated its 2022 guidance, expecting revenues between $2.825 billion and $3.025 billion.
AdaptHealth Corp. (NASDAQ: AHCO) announced that its CEO Steve Griggs, President Josh Parnes, and CFO Jason Clemens will participate in a fireside chat at the SVB Leerink Global Healthcare Conference on February 18 at 9:20 am ET. A live webcast and replay will be available on the Investors section of AdaptHealth's website. AdaptHealth is a leader in providing home healthcare solutions, serving approximately 3.6 million patients across 50 states with a range of medical products and services.
AdaptHealth Corp. (NASDAQ: AHCO) will release its Q4 and full year 2021 financial results on February 24, 2022, before market opening. A teleconference will follow at 8:30 a.m. ET for management to discuss results and recent business activities. The company is a leader in healthcare-at-home solutions, catering to approximately 3.5 million patients annually across 700 locations. Their services include home medical equipment, diabetes supplies, oxygen therapy, and more, primarily serving Medicare, Medicaid, and commercial insurance beneficiaries.
FAQ
What is the current stock price of Adapthealth (AHCO)?
What is the market cap of Adapthealth (AHCO)?
